{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:36:51Z","timestamp":1793853411483,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09524-7","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:33:24Z","timestamp":1771025604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibiotic treatment for 1\u00a0day versus 4\u20137\u00a0days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0423-9667","authenticated-orcid":false,"given":"Anouk G.","family":"Overdevest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elske","family":"Sieswerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylke","family":"Haal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Bogaards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine A. M. C.","family":"Baven \u2013 Pronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auke","family":"Bogte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam S.","family":"Boparai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"ter Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno A.","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foke","family":"van Delft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent K.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fockens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennard P. L.","family":"Gilissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Hadithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"van der Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter J.","family":"den Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akin","family":"Inderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Jan F.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd D.","family":"Kuiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Marius","family":"Munneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"Perk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Poen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Werner","family":"Poley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger","family":"Quispel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C. H.","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk W.","family":"Sch\u00f6lvinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellert J.","family":"van Soest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan C. I. T. L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels G.","family":"Venneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Verdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van de Vrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Maarten","family":"Vrolijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy L. J.","family":"van Wanrooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim W.","family":"Weijenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel G. W.","family":"Dijkgraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier P.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"1","key":"9524_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jhbp.518","volume":"25","author":"H Gomi","year":"2018","unstructured":"Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):3\u201316.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"9524_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/jhbp.509","volume":"25","author":"F Miura","year":"2018","unstructured":"Miura F, Okamoto K, Takada T, Strasberg SM, Asbun HJ, Pitt HA, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31\u201340.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"9524_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12879-022-07653-3","volume":"22","author":"E Sieswerda","year":"2022","unstructured":"Sieswerda E, Bax HI, Hoogerwerf JJ, de Boer MGJ, Boermeester M, Bonten MJM, et al. The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults. BMC Infect Dis. 2022;22(1):687.","journal-title":"BMC Infect Dis"},{"key":"9524_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jgar.2022.12.002","volume":"32","author":"C Schaub","year":"2023","unstructured":"Schaub C, Barnsteiner S, Sch\u00f6nenberg L, Bloch N, Dr\u00e4ger S, Albrich WC, et al. Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations. J Glob Antimicrob Resist. 2023;32:11\u20137.","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"9524_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/2050640620915016","volume":"8","author":"S Haal","year":"2020","unstructured":"Haal S, Ten B\u00f6hmer B, Balkema S, Depla AC, Fockens P, Jansen JM, et al. Antimicrobial therapy of 3 days or less is sufficient after successful ERCP for acute cholangitis. United Eur Gastroenterol J. 2020;8(4):481\u20138.","journal-title":"United Eur Gastroenterol J"},{"key":"9524_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.","journal-title":"BMC Infect Dis"},{"key":"9524_CR7","doi-asserted-by":"crossref","unstructured":"Iskandar K, Murugaiyan J, Hammoudi Halat D, Hage SE, Chibabhai V, Adukkadukkam S, et al. Antibiotic discovery and resistance: the chase and the race. Antibiotics (Basel). 2022;11(2):182.","DOI":"10.3390\/antibiotics11020182"},{"key":"9524_CR8","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - annual epidemiological report for 2019. ECDC: Stockholm. 2020."},{"issue":"9","key":"9524_CR9","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","volume":"177","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308\u201315.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"9524_CR10","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77.","journal-title":"Clin Infect Dis"},{"key":"9524_CR11","unstructured":"Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A practical toolkit. World Health Organization. 2019."},{"key":"9524_CR12","unstructured":"Schuts EC HM, Mouton JW, Verduin CM, Cohen Stuart JWT, Overdiek JWPM, et al. SWAB guidelines for antimicrobial stewardship. 2016."},{"key":"9524_CR13","unstructured":"UNGA Political Declaration: a global commitment to combat antimicrobial resistance (AMR): European Commission; 2024. Available from: https:\/\/health.ec.europa.eu\/latest-updates\/unga-political-declaration-global-commitment-combat-antimicrobial-resistance-amr-2024-10-01_en."},{"issue":"21","key":"9524_CR14","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2020.6348","volume":"323","author":"E von Dach","year":"2020","unstructured":"von Dach E, Albrich WC, Brunel AS, Prendki V, Cuvelier C, Flury D, et al. Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA. 2020;323(21):2160\u20139.","journal-title":"JAMA"},{"issue":"7","key":"9524_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","volume":"69","author":"D Yahav","year":"2019","unstructured":"Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, et al. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis. 2019;69(7):1091\u20138.","journal-title":"Clin Infect Dis"},{"issue":"10374","key":"9524_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0140-6736(22)02588-0","volume":"401","author":"EML de Wijkerslooth","year":"2023","unstructured":"de Wijkerslooth EML, Boerma EG, van Rossem CC, van Rosmalen J, Baeten CIM, Beverdam FH, et al. 2 days versus 5 days of postoperative antibiotics for complex appendicitis: a pragmatic, open-label, multicentre, non-inferiority randomised trial. Lancet. 2023;401(10374):366\u201376.","journal-title":"Lancet"},{"issue":"1","key":"9524_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1473-3099(24)00456-0","volume":"25","author":"SME Kuijpers","year":"2025","unstructured":"Kuijpers SME, Buis DTP, Ziesemer KA, van Hest RM, Schade RP, Sigaloff KCE, et al. The evidence base for the optimal antibiotic treatment duration of upper and lower respiratory tract infections: an umbrella review. Lancet Infect Dis. 2025;25(1):94\u2013113.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"9524_CR18","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","volume":"392","author":"N Daneman","year":"2025","unstructured":"Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, et al. Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections. N Engl J Med. 2025;392(11):1065\u201378.","journal-title":"N Engl J Med"},{"issue":"4","key":"9524_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1067\/mge.2002.122334","volume":"55","author":"AU van Lent","year":"2002","unstructured":"van Lent AU, Bartelsman JF, Tytgat GN, Speelman P, Prins JM. Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc. 2002;55(4):518\u201322.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"9524_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jhbp.512","volume":"25","author":"S Kiriyama","year":"2018","unstructured":"Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17\u201330.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"9524_CR21","doi-asserted-by":"crossref","unstructured":"IAP\/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1\u201315.","DOI":"10.1016\/j.pan.2013.07.063"},{"issue":"1","key":"9524_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jhbp.515","volume":"25","author":"M Yokoe","year":"2018","unstructured":"Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):41\u201354.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"9524_CR23","unstructured":"Sieswerda E, Bax HI, Hoogerwerf JJ, De Boer MGJ, Boermeester M, Bonten MJM, et al. The Dutch Working Party on Antibiotic Policy (SWAB) guidelines for emperical antibacterial therapy of sepsis in adults. 2020."},{"key":"9524_CR24","unstructured":"SRI-richtlijn Bijzonder resistente micro-organismen (BRMO) Modula 1a: Samenwerkingsverband Richtlijnen Infectiepreventie; 2024. Available from: https:\/\/www.sri-richtlijnen.nl\/brmo\/module-1a."},{"issue":"11","key":"9524_CR25","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.cmi.2018.01.021","volume":"24","author":"A Doi","year":"2018","unstructured":"Doi A, Morimoto T, Iwata K. Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study. Clin Microbiol Infect. 2018;24(11):1184\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"9524_CR26","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00535-011-0451-5","volume":"46","author":"H Kogure","year":"2011","unstructured":"Kogure H, Tsujino T, Yamamoto K, Mizuno S, Yashima Y, Yagioka H, et al. Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage. J Gastroenterol. 2011;46(12):1411\u20137.","journal-title":"J Gastroenterol"},{"issue":"6","key":"9524_CR27","first-page":"3020","volume":"8","author":"NLD Netinatsunton","year":"2019","unstructured":"Netinatsunton NLD, Attasaranya S, Sottisuporn J, Pattarapuntakul T, Ovartlarnporn B. Short duration versus 14-day antibiotic treatment in acute cholangitis due to bile duct stone: a randomized study. J Gastroenterol Hepatol Res. 2019;8(6):3020\u20134.","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"11","key":"9524_CR28","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1007\/s10620-014-3233-0","volume":"59","author":"TY Park","year":"2014","unstructured":"Park TY, Choi JS, Song TJ, Do JH, Choi SH, Oh HC. Early oral antibiotic switch compared with conventional intravenous antibiotic therapy for acute cholangitis with bacteremia. Dig Dis Sci. 2014;59(11):2790\u20136.","journal-title":"Dig Dis Sci"},{"key":"9524_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2016.12.018","volume":"55","author":"S Uno","year":"2017","unstructured":"Uno S, Hase R, Kobayashi M, Shiratori T, Nakaji S, Hirata N, et al. Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia. Int J Infect Dis. 2017;55:81\u20135.","journal-title":"Int J Infect Dis"},{"key":"9524_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijid.2020.04.074","volume":"96","author":"M Satake","year":"2020","unstructured":"Satake M, Yamaguchi Y. Three-day antibiotic treatment for acute cholangitis due to choledocholithiasis with successful biliary duct drainage: a single-center retrospective cohort study. Int J Infect Dis. 2020;96:343\u20137.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"9524_CR31","first-page":"e58883","volume":"16","author":"S Masuda","year":"2024","unstructured":"Masuda S, Imamura Y, Ichita C, Jinushi R, Kubota J, Kimura K, et al. Efficacy of short-course antibiotic therapy for acute cholangitis with positive blood cultures: a retrospective study. Cureus. 2024;16(4):e58883.","journal-title":"Cureus"},{"issue":"17","key":"9524_CR32","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/sim.6122","volume":"33","author":"B Klingenberg","year":"2014","unstructured":"Klingenberg B. A new and improved confidence interval for the Mantel-Haenszel risk difference. Stat Med. 2014;33(17):2968\u201383.","journal-title":"Stat Med"},{"issue":"6","key":"9524_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1445-2197.2005.03397.x","volume":"75","author":"LM Mui","year":"2005","unstructured":"Mui LM, Ng CS, Wong SK, Lam YH, Fung TM, Fok KL, et al. Optimum duration of prophylactic antibiotics in acute non-perforated appendicitis. ANZ J Surg. 2005;75(6):425\u20138.","journal-title":"ANZ J Surg"},{"issue":"2","key":"9524_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jama.2014.7586","volume":"312","author":"JM Regimbeau","year":"2014","unstructured":"Regimbeau JM, Fuks D, Pautrat K, Mauvais F, Haccart V, Msika S, et al. Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial. JAMA. 2014;312(2):145\u201354.","journal-title":"JAMA"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09524-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09524-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09524-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:44:22Z","timestamp":1774284262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09524-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9524"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09524-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Research Ethics Committee Amsterdam UMC (Amsterdam, the Netherlands) approved the trial protocol (NL80410.029.22). Local IRBs of the participating centres approved the trial protocol before the start of inclusion at the particular centre. All participants have provided written informed consent prior to trial inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participant information materials and informed consent forms are available from the corresponding author on request. No details, images, or videos relating to an individual person were used in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Lennard P.L. Gilissen received speaker\u2019s fees from AbbVie and Boston Scientific. Rogier P. Voermans reports research grants from Cook Medical and Prion Medical, performed as a consultant for Boston Scientific and Cook Medical, and received speaker\u2019s fees from Viatris. Roy L.J. van Wanrooij performed as a consultant for Boston Scientific. All outside the submitted work. All other authors have no competing interests or financial ties to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}